Sinocelltech Ltd.
Clinical trials sponsored by Sinocelltech Ltd., explained in plain language.
-
New lung cancer drug aims to outperform current standard in advanced disease
Disease control Recruiting nowThis study tests a new medicine called SCTB14 against the standard drug pembrolizumab as the first treatment for people with advanced non-small cell lung cancer that has not spread to the brain. About 246 adults with a specific tumor marker (TPS ≥10%) will receive either SCTB14 o…
Phase: PHASE3 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated May 01, 2026 10:10 UTC
-
New hope for rare protein disease: experimental combo targets amyloid buildup
Disease control Recruiting nowThis study tests whether adding an experimental drug (SCTC21C) to standard chemotherapy helps people newly diagnosed with AL amyloidosis, a rare disease where abnormal proteins build up in organs. About 90 adults will be randomly assigned to get the new combo or chemo alone. The …
Phase: PHASE3 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
New hope for painful skin condition: experimental drug aims to reduce flare-ups
Disease control Recruiting nowThis study tests an experimental drug, SCT650C, in 60 adults with moderate to severe hidradenitis suppurativa (HS), a painful skin condition causing abscesses and scarring. Participants receive either the drug or a placebo to see if it reduces skin bumps and inflammation by at le…
Phase: PHASE2 • Sponsor: Sinocelltech Ltd. • Aim: Disease control
Last updated Apr 30, 2026 15:48 UTC